Form D · Pharmaceuticals
SmartCells, Inc
Beverly, MA · CIK 0001304807
Offering snapshot reported Mar 23, 2010 · SEC filing
- Reported sold
- $1.75M Offering amount: $4M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2010 | Initial | $1,749,083 | No comparison | 29 | SEC filing |
| Jul 29, 2009 | Initial | $1,120,000 | No comparison | 36 | SEC filing |
| Dec 29, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-69790
Source: Form D, filed Mar 23, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edward Cannon | Director |
| James Herriman | Executive |
| Henry Kay | Director |
| Robert Manning | Director |
| Todd Zion | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Cummings Center Suite 419 E
Beverly, MA, 01915
Beverly, MA, 01915